Market Overview

The Heart Pump Devices Market in APAC - Forecast to 2025: Opportunities in Emerging Countries - ResearchAndMarkets.com

Share:

The "Asia-Pacific
Heart Pump Devices Market - Companies Profiles, Size, Share, Growth,
Trends and Forecast to 2025"
report has been added to ResearchAndMarkets.com's
offering.

Asia-Pacific heart pump devices market is expected to reach USD 756.15
million by 2025 and is projected to register a healthy CAGR in the
forecast period 2018 to 2025.

Prominent factors driving the growth of this market consist of
increasing incidence of cardiac disease, rapid advancement in surgical
technique in VAD implantation, increasing popularity of minimal invasive
surgical procedures in cardiology, regulatory approval of heart pump
devices are fuel the growth of heart pump devices market.

On the basis of product the Asia-Pacific heart pump devices market is
segmented into ventricular assist devices, intra-aortic balloon pump,
total artificial heart (TAH). In 2018, intra-aortic balloon pumps are
expected to dominate the Asia-Pacific heart pump devices market with
highest market shares. However, ventricular assist devices are expected
to grow at the highest CAGR in the forecast period.

On the basis of type the Asia-Pacific heart pump devices market is
categorized into implantable heart pump devices and extracorporeal heart
pump devices. In 2018, implantable heart pump devices are expected to
dominate the Asia-Pacific heart pump devices market with the highest
CAGR in the forecast period 2018 to 2025.

On the basis of therapy Asia-Pacific heart pump devices market is
segmented into bridge-to-transplant (BTT), bridge-to-candidacy (BTC)
destination therapy and others. In 2018, bridge-to-transplant (BTT) are
expected to dominate the Asia-Pacific heart pump devices market with the
highest CAGR in the forecast period 2018 to 2025.

Market Dynamics

Drivers

  • Increasing Incidence of Cardiac Diseases
  • Increasing Regulatory Approval & Reimbursement Procedure of Heart Pump
    Devices
  • Rapid Advancement in Surgical Technique for VAD Implantation
  • Increasing Popularity of Minimally Invasive Surgical Procedures in
    Cardiology

Restraint

  • High Cost of Process & Product

Opportunity

  • Emerging Countries

Challenge

  • Complications Related to LVAD

Companies Profiled

  • Abbott
  • Getinge AB
  • Teleflex Incorporated
  • Abiomed
  • Berlin Heart
  • BiVACOR Inc.
  • Calon Cardio
  • CardiacAssist Inc.
  • Jarvik Heart Inc.
  • Medtronic
  • ReliantHeart Inc.
  • SynCardia Systems LLC
  • Terumo Corporation
  • Thoratec Corporation

For more information about this report visit https://www.researchandmarkets.com/research/x7fb2r/the_heart_pump?w=4

View Comments and Join the Discussion!